Quetiapine extended release for the treatment of bipolar disorder.

about

Management of inter-episodic periods in patients with bipolar disorder

P2860

Q57612238-6F99B4A9-86BD-42AB-889E-264E4621A0CE

P2860

Quetiapine extended release for the treatment of bipolar disorder.

Item

http://www.wikidata.org/entity/Q38237319

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Quetiapine extended release for the treatment of bipolar disorder.

@en

type

Item

label

Quetiapine extended release for the treatment of bipolar disorder.

@en

prefLabel

Quetiapine extended release for the treatment of bipolar disorder.

@en

P1476

Quetiapine extended release for the treatment of bipolar disorder.

@en

P2093

Aurore Tremey

http://www.w3.org/2001/XMLSchema#string

P2860

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

Social functioning in bipolar patients: the perception and perspective of patients, relatives and advocacy organizations ? a review

Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

A systematic review of the associations between dose regimens and medication compliance.

Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.

Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies.

The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases.

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis.

P304

987-1005

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737175.2014.946407

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pierre-Michel Llorca

Ludovic Samalin

P577

2014-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25096854

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

Quetiapine extended release for the treatment of bipolar disorder.

about

P2860

P2860

Quetiapine extended release for the treatment of bipolar disorder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921